The innovative design of the PASV Valve coupled with the advanced material of the Xcela Power Injectable PICC offers an advanced solution to vascular access needs. The PASV Valve Technology design automatically resists backflow, reducing blood reflux that could lead to catheter-related complications. Effective October 1, 2008, U.S. hospitals are now cost accountable for certain medical errors and preventable medical care complications, including catheter-related bloodstream infections. At an estimated $100,000 per event which includes increased diagnostic/therapeutic costs and length of hospitalization, reducing the rate of hospital-acquired infections has become a top priority for hospital administrators and hospital infection control teams nationwide.
In addition, the Xcela PICC with PASV Valve Technology is easy to place and simple to maintain. Ease of placement is possible with the broadest array of kit configurations, Exact-Length™
About Navilyst Medical
Navilyst Medical Inc., headquartered in Marlborough, MA, was formed in February 2008 from Boston Scientific’s Fluid Management and Vascular Access business units. Its breakthrough devices, including the PASV® Valve Technology, expanded line of Xcela® Power Injectable PICCs and world-leading NAMIC® Fluid Management products, help hospitals to achieve safe, favorable outcomes for patients. The Company distributes its products worldwide and has its lead U.S. manufacturing facility in Glens Falls, NY. The name Navilyst combines the navi– of navigation and the –lyst of catalyst, encompassing how a leading medical technology enterprise drives industry-changing innovation. For more information, please visit: www.navilystmedical.com.
-30-
CONTACT: Kerri Connors, Navilyst Medical
Phone: (508) 658 7962; Email: kerri.connors@
